Literature DB >> 31177514

Serum tau concentration after diving - an observational pilot study.

Anders Rosén1,2, Nicklas Oscarsson3, Andreas Kvarnström1, Mikael Gennser4, Göran Sandström5, Kaj Blennow5,6, Helen Seeman-Lodding1, Henrik Zetterberg6,7,8,9.   

Abstract

INTRODUCTION: Increased concentrations of tau protein are associated with medical conditions involving the central nervous system, such as Alzheimer's disease, traumatic brain injury and hypoxia. Diving, by way of an elevated ambient pressure, can affect the nervous system, however it is not known whether it causes a rise in tau protein levels in serum. A prospective observational pilot study was performed to investigate changes in tau protein concentrations in serum after diving and also determine their relationship, if any, to the amount of inert gas bubbling in the venous blood.
METHODS: Subjects were 10 navy divers performing one or two dives per day, increasing in depth, over four days. Maximum dive depths ranged from 52-90 metres' sea water (msw). Air or trimix (nitrogen/oxygen/helium) was used as the breathing gas and the oxygen partial pressure did not exceed 160 kPa. Blood samples taken before the first and after the last dives were analyzed. Divers were monitored for the presence of venous gas emboli (VGE) at 10 to15 minute intervals for up to 120 minutes using precordial Doppler ultrasound.
RESULTS: Median tau protein before diving was 0.200 pg·mL⁻¹ (range 0.100 to 1.10 pg·mL⁻¹) and after diving was 0.450 pg·mL⁻¹ (range 0.100 to 1.20 pg·mL⁻¹; P = 0.016). Glial fibrillary acidic protein and neurofilament light protein concentrations analyzed in the same assay did not change after diving. No correlation was found between serum tau protein concentration and the amount of VGE.
CONCLUSION: Repeated diving to between 52-90 msw is associated with a statistically significant increase in serum tau protein concentration, which could indicate neuronal stress. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Entities:  

Keywords:  Biomarkers; Central nervous system; Decompression sickness; Diving research; Stress; Tau protein; Venous gas emboli

Mesh:

Substances:

Year:  2019        PMID: 31177514      PMCID: PMC6704001          DOI: 10.28920/dhm49.2.88-95

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  22 in total

1.  Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers.

Authors:  Diane Slats; Jurgen A H R Claassen; Petra E Spies; George Borm; Kees T C Besse; William van Aalst; Jack Tseng; Magnus J C Sjögren; Marcel G M Olde Rikkert; Marcel M Verbeek
Journal:  Neurobiol Aging       Date:  2011-08-31       Impact factor: 4.673

2.  Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study.

Authors:  Jeffrey Randall; Erik Mörtberg; Gail K Provuncher; David R Fournier; David C Duffy; Sten Rubertsson; Kaj Blennow; Henrik Zetterberg; David H Wilson
Journal:  Resuscitation       Date:  2012-08-09       Impact factor: 5.262

Review 3.  Ultrasound detection of vascular decompression bubbles: the influence of new technology and considerations on bubble load.

Authors:  S Lesley Blogg; Mikael Gennser; Andreas Møllerløkken; Alf O Brubakk
Journal:  Diving Hyperb Med       Date:  2014-03       Impact factor: 0.887

4.  Neurochemical aftermath of amateur boxing.

Authors:  Henrik Zetterberg; M Albert Hietala; Michael Jonsson; Niels Andreasen; Ewa Styrud; Ingvar Karlsson; Ake Edman; Cornel Popa; Abdullah Rasulzada; Lars-Olof Wahlund; Pankaj D Mehta; Lars Rosengren; Kaj Blennow; Anders Wallin
Journal:  Arch Neurol       Date:  2006-09

5.  Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot study.

Authors:  Pashtun Shahim; Per Arnell; Andreas Kvarnström; Anders Rosén; Daniel Bremell; Lars Hagberg; Kaj Blennow; Henrik Zetterberg
Journal:  Diving Hyperb Med       Date:  2015-12       Impact factor: 0.887

6.  Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.

Authors:  Abhay Moghekar; Joshua Goh; Ming Li; Marilyn Albert; Richard J O'Brien
Journal:  Arch Neurol       Date:  2012-02

7.  Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.

Authors:  Randall J Bateman; Guolin Wen; John C Morris; David M Holtzman
Journal:  Neurology       Date:  2007-02-27       Impact factor: 9.910

8.  Blood biomarkers for brain injury in concussed professional ice hockey players.

Authors:  Pashtun Shahim; Yelverton Tegner; David H Wilson; Jeffrey Randall; Tobias Skillbäck; David Pazooki; Birgitta Kallberg; Kaj Blennow; Henrik Zetterberg
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

9.  CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma.

Authors:  Sanna Neselius; Helena Brisby; Annette Theodorsson; Kaj Blennow; Henrik Zetterberg; Jan Marcusson
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

Review 10.  Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation.

Authors:  Claudia Cicognola; Davide Chiasserini; Lucilla Parnetti
Journal:  Front Neurol       Date:  2015-06-29       Impact factor: 4.003

View more
  2 in total

1.  Protein tau concentration in blood increases after SCUBA diving: an observational study.

Authors:  Anders Rosén; Mikael Gennser; Nicklas Oscarsson; Andreas Kvarnström; Göran Sandström; Helen Seeman-Lodding; Joel Simrén; Henrik Zetterberg
Journal:  Eur J Appl Physiol       Date:  2022-02-10       Impact factor: 3.346

2.  Sex Differences in Circulating T-Tau Trajectories After Sports-Concussion and Correlation With Outcome.

Authors:  Stefania Mondello; Vivian A Guedes; Chen Lai; Andreas Jeromin; Jeffrey J Bazarian; Jessica M Gill
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.